000
| 01581nam 2200337za 4500 |
---|
001 | 9.844404 |
---|
003 | CaOODSP |
---|
005 | 20221107152736 |
---|
007 | cr ||||||||||| |
---|
008 | 170922s2017 oncd o f000 0 eng d |
---|
022 | |z1925-0932 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH113-25/2017-15E-PDF|zH113-25/2017-15E |
---|
245 | 00|aSaflufenacil |h[electronic resource]. |
---|
260 | |aOttawa : |bHealth Canada, Pest Management Regulatory Agency, |c2017. |
---|
300 | |a5 p. : |bcharts |
---|
490 | 1 |aRegistration decision, |x1925-0940 ; |vRD2017-15 |
---|
500 | |aIssued also in French under title: Saflufénacil. |
---|
500 | |aCover title. |
---|
500 | |a"15 September 2017.” |
---|
520 | |a“Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is granting full registration for the sale and use of saflufenacil technical, Kixor and the herbicide end-use product, Detail, containing the technical grade active ingredient saflufenacil, to control broadleaf weeds in non-cropland areas"--P. 1. |
---|
530 | |aIssued also in print format. |
---|
692 | 07|2gccst|aHerbicides |
---|
692 | 07|2gccst|aCertification |
---|
692 | 07|2gccst|aToxicology |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
710 | 1 |aCanada. |bPest Management Regulatory Agency. |
---|
775 | 08|tSaflufénacil |w(CaOODSP)9.844405 |
---|
830 | #0|aRegistration decision,|x1925-0940 ; |vRD2017-15|w(CaOODSP)9.505184 |
---|
856 | 40|qPDF|s220 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-25/H113-25-2017-15-eng.pdf |
---|